Build a solid foundation in science, formulation and product development—find out more!
Most Popular in:
Updates by Region
New in Updates by Region (page 32 of 36)
Apr 05, 2006 | 06:47 PM CDT
The Australian Society of Cosmetic Chemists (ASCC) warned in a recent press release that government changes to the regulation of moisturizers containing sunscreens could put the public at a higher risk of skin cancer...
Mar 31, 2006 | 05:26 PM CST
By: David C. Steinberg, Steinberg & Associates
Methods of registering cosmetic formulations are changing. This column will desribe the online registration processes for the United States and Canada.
Mar 24, 2006 | 03:53 PM CST
The European Federation for Cosmetic Ingredients (EFfCI) released its Good Manufacturing Practice (GMP) Guide.
Mar 24, 2006 | 02:14 PM CST
Tony O’Lenick asks: What is the difference between a drug and cosmetic? David Steinberg explains.
Mar 14, 2006 | 03:02 PM CST
Products containing medicinal content and aimed at curing certain ailments will be classified as medicaments and not cosmetics, according to a court ruling in New Delhi...
Mar 01, 2006 | 04:01 PM CST
A recent paper calling for further research into the alleged link between aluminium salts in antiperspirants and breast cancer should not constitute alarm, said the CTPA.
Feb 28, 2006 | 05:27 PM CST
The Skin and Cancer Foundation Australia (SCFA) announced a new partnership to put skin care claims such as natural, antiaging and UV protection to stringent new test levels under a new product endorsement program.
Feb 20, 2006 | 11:36 AM CST
The American Academy of Dermatology (AAD) recently issued a statement in response to the U.S. Food and Drug Administration’s (FDA) decision that a black box warning be added to labels...
Feb 16, 2006 | 11:18 AM CST
The U.S. Food and Drug Administration (FDA) released a new report that examines the way the agency reviews applications for drugs and biologics that have not previously been approved by the FDA.
Feb 14, 2006 | 04:37 PM CST
Patient safety while taking isotretinoin depends on the careful oversight of the prescriber, according to the American Academy of Dermatology Association.